TickerFacts.

BillionToOne, Inc. (BLLN): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$15.71M
Year ended 2025-12-31
$33.17M
Trailing 12 months to 2026-06-30
2023-12-31: -$59.85M2024-12-31: -$46.78M2025-12-31: $15.71M$15.71M
2023-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$15.71Mn/m2026-03-11, From 2025-01-01
2024-12-31-$46.78Mn/m2026-03-11, From 2024-01-01
2023-12-31-$59.85Mn/a2026-03-11, From 2023-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
BillionToOne, Inc. (BLLN)2025-12-31$15.71Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$124.21Mn/m
Castle Biosciences Inc (CSTL)2025-12-31$28.33M-22.5%
Veracyte, Inc. (VCYT)2025-12-31$126.63M+98.5%
GRAIL, Inc. (GRAL)2025-12-31-$299.92Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$66.89Mn/m
Guardant Health, Inc. (GH)2025-12-31-$233.07Mn/m
Biodesix Inc (BDSX)2025-12-31-$23.53Mn/m
Personalis, Inc. (PSNL)2025-12-31-$79.45Mn/m

Compare BLLN, FLGT, CSTL, VCYT side by side · Screen every company in Services-Medical Laboratories ↗